| Cocrystals of quercetin with improved solubility and oral bioavailability AJ Smith, P Kavuru, L Wojtas, MJ Zaworotko, RD Shytle Molecular pharmaceutics 8 (5), 1867-1876, 2011 | 403 | 2011 |
| Structure− stability relationships in cocrystal hydrates: Does the promiscuity of water make crystalline hydrates the nemesis of crystal engineering? HD Clarke, KK Arora, H Bass, P Kavuru, TT Ong, T Pujari, L Wojtas, ... Crystal Growth & Design 10 (5), 2152-2167, 2010 | 252 | 2010 |
| Hierarchy of supramolecular synthons: persistent hydrogen bonds between carboxylates and weakly acidic hydroxyl moieties in cocrystals of zwitterions P Kavuru, D Aboarayes, KK Arora, HD Clarke, A Kennedy, L Marshall, ... Crystal growth & design 10 (8), 3568-3584, 2010 | 158 | 2010 |
| Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats AJ Smith, P Kavuru, KK Arora, S Kesani, J Tan, MJ Zaworotko, RD Shytle Molecular pharmaceutics 10 (8), 2948-2961, 2013 | 92 | 2013 |
| 2:1 Cocrystals of Homochiral and Achiral Amino Acid Zwitterions with Li+ Salts: Water-Stable Zeolitic and Diamondoid Metal–Organic Materials TT Ong, P Kavuru, T Nguyen, R Cantwell, Ł Wojtas, MJ Zaworotko Journal of the American Chemical Society 133 (24), 9224-9227, 2011 | 91 | 2011 |
| Nutraceutical co-crystal compositions M Zaworotko, H Clarke, A Kapildev, P Kavuru, RD Shytle, T Pujari, ... US Patent App. 12/663,212, 2010 | 69 | 2010 |
| Polymorphism of vanillin revisited: the discovery and selective crystallization of a rare crystal structure P Kavuru, SJ Grebinoski, MA Patel, L Wojtas, K Chadwick CrystEngComm 18 (7), 1118-1122, 2016 | 27 | 2016 |
| Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof EJ Martinez, AG Grill, A Singh, P Kavuru US Patent 9,827,217, 2017 | 11 | 2017 |
| Nutraceutical co-crystal compositions MJ Zaworotko, H Clarke, A Kapildev, P Kavuru, RD Shytle, T Pujari, ... | 9 | 2010 |
| Nutraceutical co-crystal compositions MJ Zaworotko, H Clarke, A Kapildev, P Kavuru, RD Shytle, T Pujari, ... US Patent 10,376,521, 2019 | 7 | 2019 |
| Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof EJ Martinez, AG Grill, A Singh, P Kavuru, ND Paschalides, SA Wald US Patent 9,884,813, 2018 | 7 | 2018 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF EJ Martinez, AG Grill, A Singh, P Kavuru US Patent App. 15/245,750, 2017 | 7 | 2017 |
| Lithium cocrystal compositions MJ Zaworotko, RD Shytle, TT Ong, RN Cantwell, T Nguyen, AJ Smith, ... US Patent 10,130,708, 2018 | 5 | 2018 |
| Crystal structure of ethyl 4-[(E)-(4-hydroxy-3-methoxybenzylidene) amino] benzoate: a p-hydroxy Schiff base J Ling, P Kavuru, L Wojtas, K Chadwick Acta Crystallographica Section E: Crystallographic Communications 72 (7 …, 2016 | 5 | 2016 |
| Hierarchy of Supramolecular Synthons in the of Design Multi-Component Crystals P Kavuru University of South Florida, 2012 | 3 | 2012 |
| A novel lithium cocrystal with improved oral bioavailability and targeted brain delivery RD Shytle, AJ Smith, P Kavuru, MJ Zaworotko CELL TRANSPLANTATION 21 (4), 792-792, 2012 | 2 | 2012 |
| Crystal engineering of flavonoids P Kavuru University of South Florida, 2008 | 2 | 2008 |
| Cocrystals of quercetin with improved oral bioavailability may be useful for treating neurodegenerative disease RD Shytle, AJ Smith, P Kavuru, L Wojtas, MJ Zaworotko CELL TRANSPLANTATION 21 (4), 791-792, 2012 | 1 | 2012 |
| Farmaceutski prihvatljive soli beta-gvanidinopropionske kiseline sa poboljšanim svojstvima i njihova upotreba EJ Martinez, AG Grill, A Singh HR Patent App. P20210044T T, 2021 | | 2021 |
| Farmaceutisk acceptable salte af beta-guanidinopropionsyre med forbedrede egenskaber og anvendelser deraf EJ Martinez, AG Grill, P Kavuru, A Singh | | 2021 |
